News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

|Podcasts|April 26, 2018

Insights on Purity and Intactness of AAV Gene Therapy Vectors

Author(s)Vironova

Newsletter

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

The BioPharm Brief: Fibrosis, Bispecific ADCs, and Billion-Dollar Deals

ByEmily Schoenthaler

Published: June 23rd 2026 | Updated: June 10th 2026

The BioPharm Brief: Triple Threats, TL1A Bets, and AI Brains

ByEmily Schoenthaler

Published: June 22nd 2026 | Updated: June 10th 2026

The BioPharm Brief: FDA Decisions, Vaccine Momentum, and Lymphoma Advances

ByEmily Schoenthaler

Published: June 18th 2026 | Updated: June 10th 2026

Q&A: Cytiva’s Pierre-Alain Ruffieux on Scaling Cell and Gene Therapy Manufacturing for Global Access

ByFeliza Mirasol,Pierre-Alain Ruffieux

June 17th 2026

The BioPharm Brief: Dual Targets, Treg Therapy, Tumor Responses

ByEmily Schoenthaler

Published: June 16th 2026 | Updated: June 10th 2026